Live Blog

MARKET WRAP: Sensex slips 82 pts, Nifty gives up 11,800; pharma stocks fall

All that happened in markets today

SI Reporter New Delhi
Brokers trade at their computer terminals at a stock brokerage firm in Mumbai. Photo: Reuters

2 min read Last Updated : Feb 25 2020 | 3:58 PM IST

3:58 PM

MARKET COMMENT | Vinod Nair, Head of Research, Geojit Financial Services

Markets steadied after a steep selloff yesterday as investors assessed the economic impact of coronavirus which has spread to other nations. Trump-Modi meet failed to provide any sentiment boost for the domestic market as there were no key deals . Virus concerns could remain in the limelight as any further supply disruption could hurt global economic growth in 2020.

3:43 PM

SECTOR WATCH | Nifty Pharma index bleeds the most

3:42 PM

MARKET AT CLOSE | Top losers and gainers on the S&P BSE Sensex

3:36 PM

CLOSING BELL

The S&P BSE Sensex ended 82 points or 0.2 per cent lower at 40,281 levels while the NSE's Nifty50 ended at 11,798, down 31.5 points or 0.27 per cent.

3:19 PM

MARKET CHECK

3:06 PM

RBI MPC may consider coronavirus impact on Indian economy: Report

The report titled "India: Growth and inflation targeting review", Radhika Rao, Economist at DBS Bank noted that the impact on India is felt through supply chain disruptions from China as well as regional players, who in turn are net importers from China. "Temporary price increases are likely to be accompanied by production delays if the pain spills over into 2Q20 (April-June)," the report said adding that "the MPC is also likely to consider developments around COVID-19". READ MORE  



3:03 PM

NEWS ALERT | Axis Bk to pick 17.9% stake in Max Life for Rs 550 cr: sources to CNBC TV18

>> Bank plans to hold 19.9% stake in Max Life post deal, up from 2% 

>> Post deal, Max Fin likely to own 54.5% stake in max Life

>> Axis, Max Fin have signed for exclusive engagement for 90 days

Alert: Axis Bank will buy stake in Max Life from Max Fin

3:00 PM

NEWS ALERT | Fullerton Financial considering stake sale in its Indian NBFC: Bloomberg

>> Working with an adviser on the partial divestment of Fullerton India Credit Company

>> Aims to raise $350 mn via sale

2:44 PM

Aditya Birla Fashion extends decline

2:32 PM

Navin Fluorine surges 17% on multi-year contract with a global company

The stock of the fluorochemical maker hit a new high today. It has rallied 26 per cent in the past two weeks, as compared to a 2.5 per cent decline in the S&P BSE Sensex. In the past six months, the stock has more than doubled from level of Rs 686, against a 10 per cent rise in the benchmark index. READ MORE

2:22 PM

Rupee check

2:20 PM

BROKERAGE RADAR | HDFC Securities on Hero MotoCorp

Management laid out the road map at the CIT (Center of Innovation) visit. CIT is gradually ramping up (since its commencement in 2016) and has helped reduce lead times for new product development by 25%. Hero has invested $600mn in R&D over the last few years, which is now bearing fruit. With the launch of the Xtreme 160cc bike, Hero will now address 96% of the Indian 2W market and compete effectively in the premium segment. While the customer acceptance of the new products in the ‘white spaces’ will be gradual, we re-iterate BUY as Hero has successfully defended market share in the 2W segment in the current downturn. We value the stock at 16x Dec-21 EPS, in-line with its average trading multiple.

2:11 PM

MARKET UPDATE:: Nifty slips below 11,800

2:03 PM

MARKET UDATE:: Sensex at day's low

1:08 PM

IndiGo slides 6%

Topics :MarketsMARKET WRAP

First Published: Feb 25 2020 | 7:29 AM IST